Artwork
iconShare
 
Manage episode 492212075 series 3302577
Content provided by Rare Care Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Rare Care Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Daniel Grant, MD, vice president and global program head of neuroscience and gene therapy at Swiss pharma giant Novartis, on emerging therapies for SMA.

  continue reading

190 episodes